Miromatrix Medical Inc.
NASDAQ:MIRO
3.39 (USD) • At close December 12, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 5.208 | 52.812 | 4.444 | 3.25 |
| Short Term Investments
| 19.989 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 25.197 | 52.812 | 4.444 | 3.25 |
| Net Receivables
| 1.038 | 1.275 | 0.115 | 0.528 |
| Inventory
| 0.8 | 0.8 | 0 | 0 |
| Other Current Assets
| 0.275 | 0.451 | 0.131 | 0.095 |
| Total Current Assets
| 27.311 | 55.337 | 4.69 | 3.873 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 7.219 | 5.592 | 0.325 | 0.372 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.24 | 3.475 |
| Tax Assets
| 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.233 | -5.592 | -0.564 | 0.026 |
| Total Non-Current Assets
| 7.452 | 5.592 | 0.564 | 3.873 |
| Total Assets
| 34.763 | 60.929 | 5.254 | 7.746 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 1.585 | 2.095 | 0.13 | 0.303 |
| Short Term Debt
| 0.434 | 0.392 | 6.414 | 0.265 |
| Tax Payables
| 0.113 | 0.101 | 0 | 0 |
| Deferred Revenue
| 0 | 1.917 | 1.374 | 0 |
| Other Current Liabilities
| 2.928 | 0.16 | 0.247 | 1.056 |
| Total Current Liabilities
| 4.946 | 4.564 | 8.164 | 1.623 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 3.118 | 0.439 | 0.929 | 0.873 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.591 | 1.8 | 47.196 | 46.683 |
| Total Non-Current Liabilities
| 3.709 | 2.239 | 48.124 | 47.556 |
| Total Liabilities
| 8.656 | 6.803 | 56.289 | 49.179 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 46.661 | 46.661 |
| Common Stock
| 0 | 0 | 0 | 0 |
| Retained Earnings
| -104.012 | -74.052 | -59.381 | -49.072 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -46.661 | -46.661 |
| Other Total Stockholders Equity
| 130.119 | 128.178 | 8.347 | 7.638 |
| Total Shareholders Equity
| 26.107 | 54.126 | -51.034 | -41.433 |
| Total Equity
| 26.107 | 54.126 | -51.034 | -41.433 |
| Total Liabilities & Shareholders Equity
| 34.763 | 60.929 | 5.254 | 7.746 |